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A) Experimental  
General. All the DNA manipulations and bacterial transformation were carried out 
according to the standard protocols or manufacturers’ instructions.  Synthetic 
oligonucleotides were purchased from MWG-Biotech.  Phosphoglucose isomerase from 
baker´s yeast (S. cerevisiae), glucose 6-phosphate deshydrogenase, DL-glyceraldehyde 3-
phosphate (G3P), N-benzyloxyacetaldehyde and nicotinamide adenine dinucleotide 
phosphate (NADP+) were from Sigma-Aldrich.  Antibiotics, acrylamide-bisacrylamide, 
buffer components and hydroxyacetone (HA) were from Sigma-Aldrich.  Culture media 
components for bacteria were from Pronadisa (Madrid, Spain). Dyhydroxyacetone (DHA) 
was purchased from Merck. Deionized water was used for preparative HPLC and Milli-Q-
grade water for analytical HPLC. All other solvents used were of analytical grade. N-Cbz-
aminoaldehydes used in these studies were synthesized in our lab using procedures 
published in previous works.1-3 Bacterial strains, oligonucleotides and plasmid used in this 
study are listed in Table S1.  The plasmid pQEfsa containing the gene for expression of 
FSA was constructed in our lab using routine procedures of molecular biology. 
NMR analysis: High field 1H and 13C nuclear magnetic resonance (NMR) analyses were 
carried out using an AVANCE 500 BRUKER spectrometer equipped with a high-sensitive 
CryoProbe for [D2]H2O and [D4]MeOH solutions. Full characterization of the described 
compounds was performed using typical gradient-enhanced 2D experiments: COSY, 
NOESY, HSQC and HMBC, recorded under routine conditions. When possible, NOE data 
were obtained from selective 1D NOESY versions using a single pulsed-field-gradient 
echo as a selective excitation method and a mixing time of 500 ms. When necessary, 
proton and NOESY experiments were recorded at different temperatures in order to study 
the different behavior of the exchange phenomena to avoid the presence of false NOE 
cross-peaks that complicates both structural and dynamic studies. Routine, 1H (400-500 
MHz) and 13C (101 MHz) NMR spectra of compounds were recorded with a Varian 
Mercury-400 and Varian Anova-500 spectrometers, respectively.  
Specific rotations. Analytical specific rotation values were measured with a Perkin Elmer 
Model 341 (Überlingen, Germany) polarimeter.  
Protein concentration was calculated with the method of Bradford.4  
Activity assays. The FSA activity was measured using the formation of D-fructose-6-
phosphate from dihydroxyacetone (300 mM) and D,L-glyceraldehyde 3-phosphate (2.8 
mM) in 50 mM glycylgycine buffer (pH 8.5) containing 1 mM dithiothreitol at 30 °C as 
described previously using a coupled assay using phosphoglucose isomerase and glucose-
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6-phosphate dehydrogenase.5,6 The reduction of NADP (0.5 mM) was monitored at 340 
nm for 5 min using a Cary 50 Bio UV-Visible Spectrophotometer (Varian, Darmstadt, 
Germany);  1 mmol of NADP reduced was set equivalent to 1 mmol of D-fructose-6-
phosphate formed (one U will produce 1 μmol of D-fructose-6-phosphate (D-F6P) per 
minute).  
HPLC analyses. HPLC analyses were performed on an X-BridgeTM C18, 5µm, 4.6 x 250 
mm column from Waters (Milford, USA). Samples (30 µL) were injected and eluted with 
the following conditions: solvent system: (A): aqueous  trifluoroacetic acid (TFA; 0.1% 
(v/v)) and solvent (B): TFA (0.095% (v/v)) in CH3CN/H2O (4:1), gradient elution from 10-
70 % B in 30 min, flow rate 1mL min–1, detection 215nm, column temperature 30 ºC.  The 
amount of aldol adduct produced was quantified from the peak areas using an external 
standard methodology. The detection limit for the Cbz-aldol adducts was between 0.2 to 
0.5 nmol. 
Preparative column chromatography. Bulk stationary phase Amberlite™ XAD™16 
(Rohm and Haas) was packed into a glass column (45 x 1.5 cm) to give a final bed volume 
of 200 mL.  The Amberlite™ XAD™16 was equilibrated initially with H2O and then the 
crude material dissolved in water (50-70 mL) was loaded onto the column. Impurities 
were washed away with H2O (2–3 column volumes). Then, the aldol adducts were eluted 
with EtOH (200 mL). The fractions were analyzed by HPLC. Pure fractions were pooled 
and lyophilized.   
Mutagenesis. FSA gene mutations were introduced with the QuikChange site-directed 
mutagenesis kit (QuickChange® Site-Directed Mutagenesis kit, Stratagene), using the 
plasmid pQEfsa as template and performed according to the manufacturer´s protocols. The 
oligonucleotides for amplification and mutagenesis were custom-synthesized (Table S1). 
The double mutant FSA A129S/A165G was obtained using pQEfsaFSA129S as template 
with the mutagenesis primers FSA A165G up and FSA A165G down (Table S1). The 
external primers utilized were pQE53 and pQE35.  Strain E. coli JM109 was used for 
transformations and plasmid preparation.  The resulting clones were checked by DNA 
sequencing and the proteins expressed analyzed by mass spectra.  
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Table S1: Strain, plasmids and oligonucleotides used in this study (mutagenised codons 
are highlighted in italic and bold). 
 
Plasmids Relevant genetic characteristics Ref./Origin 
pQE40 PT5, Ampr, ColE1ori Quiagen 
pQEfsa fsa gene (660bp) cloned in pQE40 (BseRI/HindIII), the C-terminal His-tagged was deleted. This study 
pQEfsaA129S fsaA129S gene cloned in pQE40  This study 
pQEfsaR134A fsaR134A gene (660bp) cloned in pQE40  This study 
pQEfsaA165G fsaA165G gene (660bp) cloned in pQE40  This study 
pQEfsaA129S/A165G fsaA129S/A165G gene (660bp) cloned in pQE40  This study 
Strains Relevant genotype Ref./Origin 
E. coli JM109 endA1, recA1, gyrA96, thi, hsdR17 (rk
–, mk+), relA1, 
supE44, Δ( lac-proAB), [F´ traD36, proAB, laqIqZΔM15]. Promega 
E. coli M15[pREP4] naIs, strs, rifs, thi-, lac-, ara+, gal+, mtl-, F-, recA+, uvr+, lon+. Qiagen 
Oligonucleotides Oligonucleotide sequences (5´? 3´) Ref./Origin 
FSAA129S up GGCAGGTGCGGAATATGTTTCGCCTTACGTTAATC This study 
FSAA129S down GATTAACGTAAGGCGAAACATATTCCGCACCTGCC This study 
FSAR134A up CCTTACGTTAATGCTATTGATGCTCAG This study 
FSAR134A down CTGAGCATCAATAGCATTAACGTAAGG This study 
FSAA165G up GAAAGTGCTGGCAGGGAGTTTCAAAACC This study 
FSAA165G down GGTTTTGAAACTCCCTGCCAGCACTTTC This study 
 
Protein expression and purification.  The plasmids were transformed into E. coli strain M-
15 [pREP-4] (QIAGEN).  Cells were grown at 37ºC in 4.8 L of a LB medium containing 
ampicillin (100 mg L–1) and kanamycin (25 mg L–1) up to an optical density of 0.6 at 600 
nm.  For protein expression, temperature was lowered to 30ºC to avoid inclusion bodies 
formation and isopropyl-β-D-thiogalactoside (IPTG) was added (final concentration of 1 
mM). After additional 4 h cells were harvested, suspended in starting buffer (50 mM 
glycylglycine, 1 mM dithiothreithol (DTT), pH 8.5) and lysed using a TS 0.75kW 40K 
Cell Disrupter (Constant Systems).  Cellular debris was removed by centrifugation at 
12000 g for 20 min.  The clear supernatant was heat-shock treated (70 ºC, 30 min) and 
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centrifuged at 12000 g for 20 min at 4 ºC.  The pellet was discarded and the supernatant 
was dialyzed against buffer glycylglycine 5 mM, DTT 0.1 mM, pH 8.5 and finally, 
lyophilized.  Proteins were analyzed by SDS-PAGE (Figure 1). 
 
Figure S1.  SDS-PAGE analysis of FSA wild-type, FSA A129S, FSA A165G and FSA 
A129S/A165G.  Protein (5 μg in all cases; FSA wild-type, 0.75 mg of protein/g 
lyophilized powder; FSA A129S, 0.8 mg of protein/g lyophilized powder; FSA A165G, 
0.33 mg of protein/g lyophilized powder and FSA A129S/A165G, 0.4 mg of protein/g 
lyophilized powder) were applied in each lane to a 12% (v/v) SDS-PAGE. Protein bands 
were visualized by staining with Coomassie Brilliant Blue R-250. Using a protein 
prestained ladder from Fermentas as standard. 
 
B) Electrospray ionization mass spectrometry of proteins.  Sample preparation: each 
protein (1 mg of lyophilized powder) was resuspended in water (1 mL) and formic acid (5 
μL) was added.  Samples (10 μL) were analyzed by HPLC-ESI-MS using an Acquity 
UPLCTM BEH300 C18 column (1.7 μm, 2.1 x 100 mm), and an ESI-TOF mass 
spectrometer (LCT PremierWaters, Milford, MA, USA) equipped with a 4GHz time-to-
digital converter (TDC) with a dual ESI source (LockSpray).  The second sprayer 
provided the lock mass calibration with leucine enkephalin (m/z 556.2771).  The ESI-TOF 
was operated in the W-optics mode, thus providing a mass resolution of at least 10 000 
full-width at half maximum (FWHM). The acquisition time per spectrum was set to 0.2 s, 
and the mass range was from 500 to 1800 Da. Data were acquired using a cone voltage of 
50 V, capillary voltage of 3000 V, desolvation temperature of 350 ºC, and source 
temperature of 100 ºC. The desolvation gas flow was set at 400 L h–1 and the cone gas 
flow was set at 30 L h–1. The solvent system used for the elution was: solvent (A): aqueous 
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formic acid 0.1 % (v/v) and solvent (B): formic acid 0.1 % (v/v) in acetonitrile, gradient 
elution 0 % B for 5 min, from 5 to 70 % B in 12 min, from 70 to 100 % B in 1 min, flow 
rate 0.3 mL min–1.  MassLynx 4.1 (Waters. Milford, MA, USA) was used for data 
acquisition and processing.  Magtran software7 kindly provided by Dr. Zhongqi Zhang 
(Amgen, Inc.; Thousand Oaks, CA) was used for molecular weight deconvolution from 
ESI-MS spectra of proteins (Figure S1 and Table S2). 
 
Table S2. Mass spectrometry of the FSA mutants. 
FSA mutants Calculated Observed Error abs (Da) 
FSA A129S 23012.82 23012.0 0.82 
FSA A165G 22982.80 22982.0 0.80 
FSA A129S A165G 22998.80 22999.0 0.20 
FSA R134A 22911.71 22911.0 0.71 
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Figure S2.  MS ESI/TOF spectra and deconvolution spectra for the FSA mutants.  a) FSA 
A129S, b) FSA A165G, c) FSA A129S A165G, d) FSA R134A. 
a)  
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d)  
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C) Specific activity of the mutants on the aldol addition reaction of dihydroxyacetone 
phosphate to D,L-glyceraldehyde-3-phosphate. 
The specific activity of the FSA wild-type and mutants was determined using the assay 
described above consisting of the synthesis of D-fructose-6-phosphate from the aldol 
addition of DHA and D,L-glyceraldehyde-3-phosphate (G3P).  As expected, the lowest 
activity was found for the FSA R134A since the acceptor G3P loss the ionic interaction 
site with the R134 residue (Table S3).  Furthermore, the A129S mutant was the most 
active, in good agreement with a previous work,8 and the double A129S/A165G had 
higher activity than that of A165G due to the putative additional stabilization of the DHA 
with the S129 residue (Table S3). 
 
Table S3 Specific aldolase activitya of the FSA wild-type and the mutants used in this 
work. 
 
Specific 
Aldolase U mg–1protein 
(Bradford) 
FSA 1.5±0.2 
FSA R134A 0.3±0.1 
FSA A129S 9.4±1.3 
FSA A165G 0.9±0.1 
FSA A129S/A165G 2.5±0.9 
aOne Unit (U) catalyzed the formation of 1 μmol of D-fructose-6-phosphate (D-F6P) per 
minute from DHA (300 mM) and D,L-glyceraldehyde-3-phosphate (D,L-GAP) (2.8 mM) at 
30 ºC in glycylglycine buffer (1 mL, 50 mM, pH 8.5) containing DTT (1 mM).5  Values are 
the average of at least three independent measurements. 
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D) Enzymatic aldol reactions  
Enzymatic aldol reactions with DHA or HA as donors (Scheme S1): Analytical scale 
reactions. A preliminary set of reactions was conducted to test the obtained mutant 
proteins with selected N-Cbz-amino aldehydes (Table S4).  Reactions (200 μL total 
volume) were performed using 1 mL test tubes stirred with a vortex mixer (VIBRAX 
VXR basic, Ika) at 800 rpm and 25 ºC.  Each of the aldehydes (0.016 mmol, 80 mM) was 
dissolved in 40 μL of dimethylformamide.  Then, to this solutions, freshly prepared DHA 
or HA solution (0.02 mmol) in 160 µL of 50 mM glycylglycine buffer pH 8, containing 
DTT (1 mM), at 25 ºC was added.  The reactions were started by adding the enzyme (0.5 
mg protein, for the units see Table S3).  At 0, 4 and 24 hours samples (25 µL) were 
withdrawn and dissolved in methanol (475 µL), and then subsequently analyzed by HPLC.  
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Scheme S1.  FSA as catalyst for the aldol addition of DHA and HA to aldehydes 1-4. 
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Table S4. Initial screening of the FSA wild-type and mutants with the selected aldehydes. 
 
  FSA wild-type
FSA 
A129S 
FSA 
A165G 
FSA 
R134A 
FSA 
A129/A165G 
Acceptor 
aldehyde Donor Aldol adduct formed (%)
a 
DHA nd nd 37 nd 75 
(S)-1 
HA 35 21 94 45 >98b 
DHA nd nd 65 nd 90 
(R)-1 
HA nd nd 90 nd 92 
DHA 20 43 95 nd >98b 
2 
HA 92 97 95 93 >98b 
DHA 8 40 63 10 >98b 
3 
HA 90 90 92 87 >98b 
DHA 68 87 85 60 94 
4 
HA 86 90 90 75 96 
aPercentage of aldol adduct formed after 24 h measured by HPLC using an external 
standard method.  Conditions: aldehyde (0.016 mmol, 80 mM), DHA (0.02 mmol, 80 mM) 
or HA (0.02 mmol, 100 mM) and the enzyme (0.5 mg) in 200 μL total volume. bno 
aldehyde left was detected by HPLC; limit of detection was between 0.2 and 0.5 nmol.  nd 
= aldol adduct not detected by HPLC. 
 
The most productive enzymes were chosen for a second set of reactions to calculate the 
initial reaction rates (νo, mmol min–1 mg–1 protein) and maximum conversions. Reactions 
(300 μL total volume) were performed as described above using 1.5 mL Eppendorf type 
test tubes: the aldehyde acceptor (0.024 mmol, 80 mM) was dissolved in 
dimethylformamide (60 μL).  Then, DHA or HA (0.030 mmol) in 210 µL of 50 mM 
glycylglycine buffer pH 8, containing DTT (1 mM) was added and equilibrated at 25 ºC.  
The reaction was initiated by the addition of the corresponding FSA mutant and mixing. 
The amount of enzyme varied from 0.05 to 1 mg of protein (for Units see Table 1 in the 
paper) to ensure a linear dependence of the product formation versus time at the beginning 
of the reaction (reaction conversions <15%). Reactions were placed in a vibrax mixer (800 
rpm) at 25 ºC. At different reaction time (FSA wild-type and FSA A129S: conversion 0 h 
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and 24 h; vo between 0 and 120 min; FSA A165G and FSA A129S/A165G conversion 0 
and 24 h;vo between 0 and 30 min), samples (25 µL) were withdrawn, mixed with 
methanol (975 µL) centrifuged to removed the precipitated protein, and analyzed directly 
by HPLC.  Concentration of products was calculated from the peak areas using an external 
standard method. Conversions were calculated with respect to the initial concentration of 
aldehyde acceptor, which were the limiting reactants.  Linear correlations were found for 
conversion <15 %.  HPLC conditions and sample concentration were adjusted to assure 
minimum error with the external standard methodology. 
The stereochemical outcome of the reactions, particularly with the FSA A129/A165G 
double mutant, was assessed by following our previously reported methodologies.1  
Analytical and preparative scale reactions were performed for the selected aldehydes, and 
the corresponding aldol adducts converted into iminocyclitols.  The NMR spectra of the 
crude were compared to those previously published with FSA wild-type and D-fructose-
1,6-bisphophate aldolase (see below).1,3,9,10   
 
E) Steady-state kinetic parameters for DHA and N-Cbz-3-aminopropanal (4).  To 
determine the  and  values for DHA and N-Cbz-3-aminopropanal for the aldol 
reaction of DHA to 4 catalyzed by FSA wild-type, FSA A129S, FSA A165G and the 
double mutant FSA A129S/A165G, analytical scale reactions (total volume was 300 μL) 
were conducted in eppendorf type tubes (1.5 mL), stirred with a vortex mixer (VIBRAX 
VXR basic, Ika) at 800 rpm and 25 ºC.   
appKm
appVmax
Steady-state kinetic parameters for DHA.  Aldehyde 4 (30 μmol) was dissolved in 
dimethylformamide (60 μL) and mixed with a solution (190 μL) containing different 
amounts of DHA (6, 12, 18 and 45, μmol for FSA wild-type, FSA A129S and FSA 
A129S/A165G and 6, 9, 12, 18 , 30 and 45, μmol for FSA A165G) in glycylglycine buffer 
(50 mM pH 8) containing DTT (1 mM). To this mixture, the aldolase, FSA wild-type, FSA 
A129S, FSA A165G or FSA A129S A165G (50 μL, containing a range of protein between 
0.1 to 0.85 mg depending on the reaction) was added to start the reaction. For each DHA 
concentration, samples (25 μL) were withdrawn at different times (in a range between 0-
30 min depending on the reaction), diluted with methanol (475 μL), centrifuged and 
analyzed by HPLC as described for the determination of initial velocities. The 
experimental and fitted data of the aldolase activity vs DHA concentration, was adjusted 
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by computer-based nonlinear regression of untransformed data to the kinetic Michaelis-
Menten equation using GraphPad Prism software (see Figure S2) 
 
 
 
Figure S3.  Activity (μmol of aldol adduct formed min–1 mg–1 of protein) of FSA wild-
type (■), FSA A129S (?), FSA A165G (?) and FSA A129S/A165G (?) at different 
DHA concentrations for the aldol addition of DHA to 4.  Experimental data was adjusted 
(solid lines) by a computer non-linear regression method to the Michaelis-Menten 
equation.  Standard deviations were calculated from experiments performed by triplicate.  
 
Steady-state kinetic parameters for N-Cbz-3-aminopropanal.  DHA (90 μmol) was 
dissolved in 190 μL of glycylglycine buffer (50 mM pH 8) containing DTT (1 mM), and 
mixed with a solution of dimethylformamide (60 μL) containing different amounts of N-
Cbz-3-aminopropanal (3, 6, 7.5, 9, 12, 18, 24, 36, 45 and 60 μmol for FSA wild-type; 3, 6, 
9, 12, 15, 18, 24, 36, 45 and 60 μmol for FSA A129S; 3, 6, 9, 12, 18, 24 and 42 μmol for 
FSA A165G and 3, 6, 9, 12, 18, 24, 36 and 42 for FSA A129S/A165G). To this mixture, 
the aldolase, FSA wild-type, FSA A129S, FSA A165G or FSA A129S A165G, (50 μL, 
containing a range of protein between 0.1 to 0.85 mg depending on the reaction) was 
added to start the reaction (total final volume, 300 μL). For each reaction, samples (25 μL) 
were withdrawn at different times (in a range between 0-30 min depending on the 
reaction), diluted with methanol (475 μL), centrifuged and analyzed by HPLC as 
described above.   
The experimental and fitted data of the aldolase activity vs N-Cbz-3-aminopropanal 
concentration, was adjusted by computer-based nonlinear regression of untransformed 
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data to the kinetic Michaelis-Menten equation using GraphPad Prism software (see Figure 
S3) 
a) 
 
b) 
 
 
Figure S4.  Activity (μmol of aldol adduct formed min–1 mg–1 of protein) of FSA wild-
type (■), FSA A129S (?), FSA A165G (?) and FSA A129S/A165G (?) at different N-
Cbz-3-aminopropanal (4) concentrations for the aldol addition of DHA to 4.  Curve a) for 
FSA wild-type type and mutants, curve b) only for FSA wild-type, FSA A129S and 
FSAA165G.  Experimental data was adjusted (solid lines) by a computer non-linear 
regression method to the Michaelis-Menten equation.  Standard deviations were calculated 
from experiments performed by triplicate.  
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F) Scale up of the aldol addition of DHA and HA to aldehydes catalyzed by FSA 
A129S/A165G.  General procedure.  Reactions were conducted in 50 mL screw capped 
conical-bottom polypropylene test tubes with 12.5 mL total reaction volume using the 
same reactant and enzyme concentration and procedure used in the corresponding 
analytical reactions:  aldehydes (1 mmol) and DHA or HA (1.25 mmol) in 50 mM 
NaHCO3-Na2CO3 buffer pH 7.5.  When the product concentration was constant by HPLC 
(~24h, conversions similar to those described for analytic reactions), a simple work 
up/purification on Amberlite™ XAD™16 column was carried out. The fractions were 
analyzed by HPLC. Pure fractions were pooled and lyophilized obtaining the 
corresponding aldol adducts (5S)-5 (248 mg, 0.83 mmol, 83% isolated yield), (5S)-6 (257 
mg, 0.91 mmol, 91% isolated yield), (5R)-5 (214 mg, 0.72 mmol, 72% isolated yield), 
(5R)-6 (220 mg, 0.78 mmol, 78% isolated yield); aldol adduct 7 (2 (14 mmol) and DHA 
(18 mmol), 2.3 g, 82 % isolated yield).  The aldol adducts 8, 9, 10, 11 and 12 were 
prepared at analytical scale (2 mL, 10-20 mg of pure material).  The aldol adducts (5S)-5, 
(5S)-6, (5R)-5, (5R)-6, 7, 8, 11 and 12 were converted into the corresponding 
iminocyclitols.  To this end, products were dissolved in H2O/MeOH 1:1 and treated with 
H2 (50 psi) in the presence of Pd/C (100 mg) at room temperature during 24 h.  After 
removal of the catalyst by filtration through 0.45 μm nylon membrane filter, the filtrates 
were adjusted to pH 6.4 with formic acid and lyophilized obtaining an oil-like material, 
which was not further purified.  This material was analyzed by NMR and the iminocyclitol 
structures were unequivocally assigned.  The 1H, 13C NMR spectra of the iminocyclitols 
from aldol adducts (5R)-5, (5S)-5, 7, 8, and 12 matched those previously reported using D-
fructose-1,6-bisphosphate aldolase from rabbit muscle (RAMA) and FSA wild-type.1,3,10 
1H and 13C NMR of iminosugar from aldol adduct 12 matched that reported by Sugiyama 
et al.10  1H and 13CNMR of aldol adducts 9, 10 and 11 were indistinguishable from those 
reported previously by us.1  Specific rotation of the iminocyclitols from the aldol adducts 
7, 8 and 11 were coincident to those reported and obtained using similar experimental 
procedure but using FSA wild-type.1 
The physical and spectral data of the iminocyclitols prepared using the FSA 
A129S/A165G that could not be previously prepared by FSA wild-type are the following 
(Scheme S2): 
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Scheme S2.  Formation of iminocyclitols 13-18 from aldol adducts (5S)-5, (5R)-5, (5S)-6 
and (5R)-6 by means of deprotection of the Cbz group and reductive amination with H2 in 
the presence of Pd/C. 
 
Specific rotation of the iminocyclitols 13+14 (as a mixture 10:1, arising from the reductive 
amination step) and 17 from the aldol adducts (5S)-5 and (5R)-5, respectively as formiate 
salts: 13:14 10:1; [α]D22 = + 32.8 (c=0.7 in MeOH) (lit.3 [α]D22 = + 16.0 (c=0.4 in MeOH); 
lit.11[α]D22 = – 43.30 (C=0.8 in H2O); lit.12 [α]D22 = + 22.7 (c=1.2 in MeOH)) and 17; 
[α]D22 = + 26.7 (c=0.6 in MeOH) (lit.3 [α]D22 = + 18.7 (c=1 in MeOH); lit.13 [α]D = + 26.2 
(c=1.1, in MeOH)] for the natural compound; lit.12 [α]D22 = + 39.1 (c=0.8 in MeOH)).  1H, 
13C NMR spectra matched those already published (see below for a copy of the 
spectra).3,12,13 
1H, 13C NMR spectra (see below for a copy of the spectra) and the specific rotation of the 
iminocyclitols 15+16 (as a mixture 4:1 arising from the reductive amination step) and 18 
from aldol adduct (5S)-6 and (5R)-6, respectively.  15+16 (as a mixture 4:1) [α]D22 = + 
18.3 (c=0.93 in H2O).  (2R,3R,4R,5S)-2,5-Dimethylpyrrolidine-3,4-diol (15) (79%): 1H 
NMR (500 MHz, D2O) δ = 4.03 (m, 1H), 3.94 (dd, J = 3.1, 1.7 Hz, 1H), 3.77 (m, 1H), 
3.46 (m, 1H), 1.40 (d, J = 7.2 Hz, 3H), 1.30 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, 
D2O) δ = 83.0, 79.1, 64.2, 60.8, 18.8, 13.0.  (2S,3R,4R,5S)-2,5-Dimethylpyrrolidine-3,4-
diol (16) (21%) 1H NMR (500 MHz, D2O) δ = 4.11 (d, J = 3.0 Hz, 1H), 3.86 (m, 1H), 1.28 
(d, J = 7.0 Hz, 3H).  13C NMR (101 MHz, D2O) δ = 78.6, 59.9, 13.0. 
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(2R,3R,4R,5R)-2,5-Dimethylpyrrolidine-3,4-diol (18). [α]D22 = + 26.7 (c=0.3 in H2O). 1H 
NMR (500 MHz, D2O) δ = 3.74 (m, 1H), 3.39 (m, 1H), 1.31 (d, J = 7.0 Hz, 3H).  13C 
NMR (101 MHz, D2O) δ = 82.48 (s), 59.53 (s), 17.92 (s). 
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Figure S5.  Observed NMR spectra of the iminocyclitols 13 (major product, i.e. 2,5-
imino-1,2,5-trideoxy-D-glucitol) and 14 obtained from the aldol adduct (5S)-5 mediated by 
FSA A129S/A165G double mutant.  a) 1HNMR, b) 13C. 
a)  
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b) 
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Figure S6.  Observed NMR spectra of the iminocyclitols 15 (major) and 16 (minor) 
obtained from the aldol adduct (5S)-6 mediated by FSA A129S/A165G double mutant.  a) 
1HNMR, b) 13C, c)  2D 1H-1H COSY and 2D multiplicity-edited HSQC and d) selective 
1D NOESY spectra. 
a) 
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b) 
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d) 
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Figure S7.  NMR spectra of 2,5-imino-1,2,5-trideoxy-D-mannitol (6-deoxy-DMDP) 17 
obtained from the aldol adduct (5R)-5 mediated by the FSA A129S/A165G double mutant. 
a) 1HNMR and b) 13CNMR. 
 
a)
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Figure S8.  Observed 1H and 13CNMR spectra of the iminocyclitol 18 obtained from the 
aldol adduct (5R)-6 mediated by the FSA A129S/A165G double mutant.  
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Figure S9.  Observed 1HNMR spectrum of 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) 
obtained from the aldol adduct 7.  a) product from the FSA A129S/A165G double mutant. 
b) product from the FSA wild-type. 
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E) Computational Methods. 
Protein-substrate models were built with the package Schrödinger Suite 2010 
(Schrödinger, LLC, New York, NY, 2010) through its graphical interphase Maestro.14 The 
program Macromodel15 with its default force field OPLS 2005, a modified version of the 
OPLS-AA force field,16 and GB/SA water solvation conditions17 were used for all energy 
calculations. Coordinates of E. coli D-fructose-6-phosphate aldolase (FSA) were obtained 
from the Protein Data Bank18 at Brookhaven National Laboratory (entry 1L6W). The 
1L6W structure is a homodecamer formed by two packed ring-like pentamers.19  A major 
interaction within each pentamer is through the C-terminal helix from one monomer 
(residues 199-215), which runs across the active site of the neighboring subunit. 
Therefore, in order to reduce the computational cost, a large fragment from one monomer 
(chain A, residues 1-199), containing one catalytic centre, and a small fragment of the 
contiguous one (chain B, residues 199-220) were used to built the protein-substrate 
models. The structure of the FSA A129S/A165G was generated by mutating in silico the 
wild-type protein. Protein structures were prepared using the Protein Preparation Wizard 
included in Maestro to remove solvent molecules and ions, adding hydrogens, setting 
protonation states and minimizing the energy using the OPLS force field. The hemiaminal 
covalent complexes of fructose-6-phosphate bound into the active centre of FSA wild-type 
and of (5R)- and (5S)-5 bound into the active centre of the FSA A129S/A165G mutant 
were modeled by modification of a bound glyceraldehide molecule present in the crystal 
structure. The structures of the protein-substrate complexes were minimized, first applying 
constraints to the protein (force constant = 25 kcal Å–2 mol–1) to avoid large changes on its 
structure, and afterwards allowing free movement of the whole system. Then the 
conformational space of the bound hemiaminal ligands was sampled using the mixed 
torsional – low mode conformational search method implemented in Macromodel.20 
Finally, the lowest energy conformers found were further minimized allowing free 
movement of the whole system until reaching a gradient <0.01 kcal mol-1 Å-1.  Figures 
were prepared with the software package MOE.21 
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